Stoke Therapeutics (STOK) Enterprise Value (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Stoke Therapeutics | 1.92 Bn | 1.92 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.68% |
| Dec 31, 2025 | -241.36% |
| Sep 30, 2025 | 17.88% |
| Jun 30, 2025 | 71.58% |
| Mar 31, 2025 | -64.74% |
| Dec 31, 2024 | -44.51% |
| Sep 30, 2024 | 22.45% |
| Jun 30, 2024 | -8.38% |
| Mar 31, 2024 | 11.33% |
| Dec 31, 2023 | 6.21% |
| Sep 30, 2023 | 7.23% |
| Jun 30, 2023 | 8.76% |
| Mar 31, 2023 | -10.49% |
| Dec 31, 2022 | 8.77% |
| Sep 30, 2022 | 8.70% |
| Jun 30, 2022 | 6.00% |
| Mar 31, 2022 | -33.40% |
| Dec 31, 2021 | -47.34% |
| Sep 30, 2021 | 40.62% |
| Jun 30, 2021 | 6.14% |
| Mar 31, 2021 | 6.84% |
| Dec 31, 2020 | -50.06% |
| Sep 30, 2020 | 5.18% |
| Jun 30, 2020 | 4.43% |
| Mar 31, 2020 | 5.03% |
| Dec 31, 2019 | 4.54% |
| Sep 30, 2019 | 3.97% |
| Jun 30, 2019 | -146.00% |
| Mar 31, 2019 | 6.40% |
| Dec 31, 2018 | -444.22% |
| Sep 30, 2018 | -102.88% |